Tagata, Letecia M.
HRN: 21-37-73 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2025
CO-AMOXICLAV 625MG (TAB)
06/09/2025
06/16/2025
PO
625mg
TID
Cap
Checking Initial Appropriateness